DRPLA Research Manager, Dr Silvia Prades, interviews Dr Hector Garcia-Moreno and Ola Volhin about the DRPLA Natural History and Biomarkers Study. Ataxia UK and CureDRPLA are coordinating this study and the funding is provided by CureDRPLA.
This is a global study with study sites in London, New York and North Carolina, all of which are currently recruiting participants. The study also plans to open sites in Japan, where DRPLA is more prevalent.
If you are based in the UK and would like to participate or receive more information, please contact:
Dr Hector Garcia-Moreno and Ms Ola Volhin
UCL Queen Square Institute of Neurology, London WC1N 3BG
Find more about the study here.